Profil
Ehud Shoshani served as the Chief Executive Officer at Quintiles UK Ltd.
and as the Medical Director at OMRIX Biopharmaceuticals, Inc. and Gamida Cell Ltd.
He also worked as the Vice President-Clinical Affairs at Aevi Genomic Medicine, Inc. Shoshani holds a doctorate degree from Technion-Israel Institute of Technology, which he received in 1978.
Ehemalige bekannte Positionen von Ehud Shoshani
| Unternehmen | Position | Ende |
|---|---|---|
| GAMIDA CELL LTD. | Technik-/Wissenschafts-/F&E-Leiter | - |
| Quintiles UK Ltd. | Präsident | - |
OMRIX Biopharmaceuticals, Inc.
 OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Technik-/Wissenschafts-/F&E-Leiter | - |
| AEVI GENOMIC MEDICINE, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Ehud Shoshani
| Technion-Israel Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GAMIDA CELL LTD. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Aevi Genomic Medicine, Inc.
 Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engaged in the discovery of treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA. | Health Technology |
| Quintiles UK Ltd. | |
OMRIX Biopharmaceuticals, Inc.
OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Health Technology |
